The Imbalance Between Oxygen Demand and Supply as a Potential Mechanism in the Pathophysiology of Heart Failure: The Role of Microvascular Growth and Abnormalities

[1]  H. Crijns,et al.  Impairment of myocardial blood flow reserve in patients with asymptomatic left ventricular dysfunction: Effects of ACE-inhibition with perindopril , 2001, The International Journal of Cardiovascular Imaging.

[2]  R. Wiesner,et al.  Expression of vascular endothelial growth factor during the development of cardiac hypertrophy in spontaneously hypertensive rats , 1998, Molecular and Cellular Biochemistry.

[3]  O. Hudlická,et al.  Factors involved in capillary growth in the heart , 1995, Molecular and Cellular Biochemistry.

[4]  M. Zile,et al.  Alterations in the myocardial capillary vasculature accompany tachycardia-induced cardiomyopathy , 2004, Basic Research in Cardiology.

[5]  R. Henning,et al.  Identification of a specific pattern of downregulation in expression of isoforms of vascular endothelial growth factor in dilated cardiomyopathy , 2002, Heart.

[6]  M. Quiñones,et al.  Microvascular Structural Correlates of Myocardial Contrast Echocardiography in Patients With Coronary Artery Disease and Left Ventricular Dysfunction: Implications for the Assessment of Myocardial Hibernation , 2002, Circulation.

[7]  R. Bache,et al.  Nitric Oxide Modulates Myocardial Oxygen Consumption in the Failing Heart , 2002, Circulation.

[8]  Jeroen J. Bax,et al.  Abnormalities in myocardial contractility, metabolism and perfusion reserve in non-stenotic coronary segments in heart failure patients. , 2002, Cardiovascular research.

[9]  R. Shannon,et al.  Angiotensin-Converting Enzyme Inhibitors Improve Coronary Flow Reserve in Dilated Cardiomyopathy by a Bradykinin-Mediated, Nitric Oxide-Dependent Mechanism , 2002, Circulation.

[10]  J. Cooke,et al.  Nitric oxide and angiogenesis. , 2002, Circulation.

[11]  D. Warltier,et al.  Angiostatin Inhibits Coronary Angiogenesis During Impaired Production of Nitric Oxide , 2002, Circulation.

[12]  M. Salis,et al.  Angiotensin AT1 receptor signalling modulates reparative angiogenesis induced by limb ischaemia , 2002 .

[13]  M. Salis,et al.  Angiotensin AT1 receptor signalling modulates reparative angiogenesis induced by limb ischaemia , 2002, British journal of pharmacology.

[14]  T. Niitsuma,et al.  Alterations of endothelium-dependent and -independent regulation of coronary blood flow during heart failure. , 2002, American journal of physiology. Heart and circulatory physiology.

[15]  A. Takeshita,et al.  Increased inactivation of nitric oxide is involved in impaired coronary flow reserve in heart failure. , 2001, American Journal of Physiology. Heart and Circulatory Physiology.

[16]  Y. Shen,et al.  Mechanisms whereby rapid RV pacing causes LV dysfunction: perfusion-contraction matching and NO. , 2001, American journal of physiology. Heart and circulatory physiology.

[17]  B. Lévy,et al.  Proangiogenic Effect of Angiotensin-Converting Enzyme Inhibition Is Mediated by the Bradykinin B2 Receptor Pathway , 2001, Circulation research.

[18]  A. Pries,et al.  Microcirculation in Hypertension: A New Target for Treatment? , 2001, Circulation.

[19]  H. Crijns,et al.  Abnormal contractile responses during dobutamine stress echocardiography in patients with idiopathic dilated cardiomyopathy. , 2001, European journal of heart failure.

[20]  J. Kaski,et al.  Rarefaction of skin capillaries in patients with anginal chest pain and normal coronary arteriograms. , 2001, European heart journal.

[21]  TakashiMiyauchi,et al.  Novel Molecular Mechanism of Increased Myocardial Endothelin-1 Expression in the Failing Heart Involving the Transcriptional Factor Hypoxia-Inducible Factor-1α Induced for Impaired Myocardial Energy Metabolism , 2001 .

[22]  Y. Kakinuma,et al.  Novel Molecular Mechanism of Increased Myocardial Endothelin-1 Expression in the Failing Heart Involving the Transcriptional Factor Hypoxia-Inducible Factor-1&agr; Induced for Impaired Myocardial Energy Metabolism , 2001, Circulation.

[23]  P. Wagner,et al.  Chronic hypoxia attenuates resting and exercise-induced VEGF, flt-1, and flk-1 mRNA levels in skeletal muscle. , 2001, Journal of applied physiology.

[24]  K. Rakušan,et al.  Effect of anemia on cardiac function, microvascular structure, and capillary hematocrit in rat hearts. , 2001, American journal of physiology. Heart and circulatory physiology.

[25]  P. Poole‐Wilson,et al.  Coronary artery disease as the cause of incident heart failure in the population. , 2001, European heart journal.

[26]  D. J. Veldhuisen,et al.  Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure , 2001, European journal of heart failure.

[27]  M. Hendrix,et al.  Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-beta. , 2001, American journal of physiology. Heart and circulatory physiology.

[28]  Y. Mori,et al.  Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. , 2001, Circulation research.

[29]  M. Hendrix,et al.  Erratum: Mechanisms of coronary angiogenesis on response to stretch: Role of VEGF and TGF-β (American Journal of Physiology - Heart and Circulatory Physiology (February 2001) 280 (H909-H917)) , 2001 .

[30]  A. Zeiher,et al.  Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol. , 2000, Journal of the American College of Cardiology.

[31]  Y. Pinto,et al.  Reduction in Left Ventricular Messenger RNA for Transforming Growth Factor &bgr;1 Attenuates Left Ventricular Fibrosis and Improves Survival Without Lowering Blood Pressure in the Hypertensive TGR(mRen2)27 Rat , 2000, Hypertension.

[32]  H. Traxler,et al.  Selective Downregulation of VEGF-A165, VEGF-R1, and Decreased Capillary Density in Patients With Dilative but Not Ischemic Cardiomyopathy , 2000, Circulation research.

[33]  C. Brilla,et al.  Lisinopril-Mediated Regression of Myocardial Fibrosis in Patients With Hypertensive Heart Disease , 2000, Circulation.

[34]  E. Ritz,et al.  Endothelin A receptor blockade prevents capillary/myocyte mismatch in the heart of uremic animals. , 2000, Journal of the American Society of Nephrology : JASN.

[35]  Katherine C. Wu,et al.  Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. , 2000, Circulation.

[36]  L. Stanton,et al.  Altered patterns of gene expression in response to myocardial infarction. , 2000, Circulation research.

[37]  W. Schaper,et al.  Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. , 2000, Circulation research.

[38]  K. Hillan,et al.  Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury. , 2000, Circulation.

[39]  W. Hsueh,et al.  Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. , 2000, Circulation.

[40]  S H Lee,et al.  Early expression of angiogenesis factors in acute myocardial ischemia and infarction. , 2000, The New England journal of medicine.

[41]  M. Bristow.  β-Adrenergic Receptor Blockade in Chronic Heart Failure , 2000 .

[42]  G. Zhao,et al.  Reduced NO-dependent arteriolar dilation during the development of cardiomyopathy. , 2000, American journal of physiology. Heart and circulatory physiology.

[43]  H. Crijns,et al.  Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. , 2000, Journal of the American College of Cardiology.

[44]  M. Bristow.  beta-adrenergic receptor blockade in chronic heart failure. , 2000, Circulation.

[45]  E. Schiffrin,et al.  Cardiac microvasculature in DOCA-salt hypertensive rats : effect of endothelin ET(A) receptor antagonism. , 1999, Hypertension.

[46]  J. Isner,et al.  Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. , 1999, The Annals of thoracic surgery.

[47]  A. Levy.  A cellular paradigm for the failure to increase vascular endothelial growth factor in chronically hypoxic states. , 1999, Coronary artery disease.

[48]  I. Buschmann,et al.  Arteriogenesis, the good and bad of it. , 1999, Cardiovascular research.

[49]  J. Ramires,et al.  Different microcirculatory and interstitial matrix patterns in idiopathic dilated cardiomyopathy and Chagas’ disease: a three dimensional confocal microscopy study , 1999, Heart.

[50]  D. Stewart,et al.  Potential role of the microvasculature in progression of heart failure. , 1999, The American journal of cardiology.

[51]  M. Post,et al.  Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. , 1999, Circulation.

[52]  J. Schaper,et al.  Effect of long-term ACE inhibition on myocardial tissue in hypertensive stroke-prone rats. , 1999, Journal of molecular and cellular cardiology.

[53]  George E Taffet,et al.  Myocardial infarction and remodeling in mice: effect of reperfusion. , 1999, American journal of physiology. Heart and circulatory physiology.

[54]  R. Bjercke,et al.  Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. , 1999, Circulation research.

[55]  M. Morton,et al.  Myocardial blood flow and coronary reserve in chronically anemic fetal lambs. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[56]  S. Masuda,et al.  Erythropoietic, neurotrophic, and angiogenic functions of erythropoietin and regulation of erythropoietin production. , 1999, International journal of hematology.

[57]  G. Yancopoulos,et al.  Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.

[58]  J. Isner,et al.  Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. , 1999, Circulation.

[59]  J. Bronzwaer,et al.  Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. , 1999, Circulation.

[60]  M A Konerding,et al.  Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. , 1999, Circulation.

[61]  A. Kitabatake,et al.  Beneficial effect of myocardial angiogenesis on cardiac remodeling process by amlodipine and MCI-154. , 1999, American journal of physiology. Heart and circulatory physiology.

[62]  L. Gnudi,et al.  Interaction of Angiotensin Ii and Mechanical Stretch on Vascular Endothelial Growth Factor Production by Human Mesangial Cells , 2022 .

[63]  P. Saxena,et al.  Early captopril prevents myocardial infarction-induced hypertrophy but not angiogenesis. , 1999, European journal of pharmacology.

[64]  M. Serio,et al.  Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. , 1999, Journal of the American Society of Nephrology : JASN.

[65]  Assessing the Coronary Circulation in Hypertension , 1999 .

[66]  B. Aggarwal,et al.  VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  J. LaManna,et al.  Prolonged hypoxia increases vascular endothelial growth factor mRNA and protein in adult mouse brain. , 1999, Journal of applied physiology.

[68]  J. Isner,et al.  Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. , 1998, Circulation.

[69]  S. Edgar,et al.  Microvascular involvement in cardiac pathology. , 1998, Journal of molecular and cellular cardiology.

[70]  L. Aiello,et al.  Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. , 1998, Diabetes.

[71]  M. Daemen,et al.  Early captopril treatment inhibits DNA synthesis in endothelial cells and normalization of maximal coronary flow in infarcted rat hearts. , 1998, Cardiovascular research.

[72]  B. Strauer,et al.  Assessing the coronary circulation in hypertension. , 1998, Journal of hypertension.

[73]  B. Lévy,et al.  Microvasculature in angiotensin II-dependent cardiac hypertrophy in the rat. , 1998, Hypertension.

[74]  M. Lesch,et al.  Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure. , 1998, American journal of physiology. Heart and circulatory physiology.

[75]  R. Ferrari,et al.  Endothelial function and dysfunction in heart failure. , 1998, European heart journal.

[76]  G. Semenza,et al.  Hypoxia-inducible factor 1: from molecular biology to cardiopulmonary physiology. , 1998, Chest.

[77]  E. Ritz,et al.  Myocyte/capillary mismatch in the heart of uremic patients. , 1998, Journal of the American Society of Nephrology : JASN.

[78]  R. Tomanek,et al.  Early coronary angiogenesis in response to thyroxine: growth characteristics and upregulation of basic fibroblast growth factor. , 1998, Circulation research.

[79]  K. Suzuma,et al.  Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. , 1998, Circulation research.

[80]  G. Semenza,et al.  Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. , 1998, American journal of obstetrics and gynecology.

[81]  R. Hamdy,et al.  Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. , 1998, Biochimica et biophysica acta.

[82]  G. Feuerstein,et al.  Carvedilol: preclinical profile and mechanisms of action in preventing the progression of congestive heart failure. , 1998, European heart journal.

[83]  H. Crijns,et al.  Ischemia and left ventricular dysfunction: a reciprocal relation? , 1998, Journal of cardiovascular pharmacology.

[84]  B. Gersh,et al.  The open-artery hypothesis. , 1998, Annual review of medicine.

[85]  W. Colucci.  Molecular and cellular mechanisms of myocardial failure. , 1997, The American journal of cardiology.

[86]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 , 1998 .

[87]  H. Kishida,et al.  Increased accumulation of acidic fibroblast growth factor in left ventricular myocytes of patients with idiopathic cardiomyopathy. , 1997, American heart journal.

[88]  E. Ritz,et al.  Rats with moderate renal failure show capillary deficit in heart but not skeletal muscle. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[89]  K. Fukuchi,et al.  Contribution of hypoxia to the development of cardiomyopathy in hamsters. , 1997, Cardiovascular research.

[90]  A. Harris,et al.  Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[91]  J. Jackson,et al.  Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta. , 1997, The Journal of rheumatology.

[92]  Jian Li,et al.  Stretch-induced VEGF expression in the heart. , 1997, The Journal of clinical investigation.

[93]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[94]  A C Shore,et al.  Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. , 1997, The Journal of clinical investigation.

[95]  M. Krasnow,et al.  The Hypoxic Response: Huffing and HIFing , 1997, Cell.

[96]  B. Strauer,et al.  Left ventricular hypertrophy and coronary microcirculation in hypertensive heart disease. , 1997, Blood pressure. Supplement.

[97]  S. Moncada,et al.  Expression of inducible nitric oxide synthase in human heart failure. , 1997, Circulation.

[98]  M. Heron,et al.  Early and late effect of neonatal hypo- and hyperthyroidism on coronary capillary geometry and long-term heart function in rat. , 1997, Cardiovascular research.

[99]  J. Folkman,et al.  Blood Vessel Formation: What Is Its Molecular Basis? , 1996, Cell.

[100]  V. Hombach,et al.  Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. , 1996, Circulation.

[101]  Takayuki Asahara,et al.  Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb , 1996, The Lancet.

[102]  L. Brown,et al.  VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. , 1996, The American journal of physiology.

[103]  M. Zeier,et al.  Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine. , 1996, Journal of the American Society of Nephrology : JASN.

[104]  K. Rakušan,et al.  The effect of AT1 receptor antagonist on chronic cardiac response to coronary artery ligation in rats. , 1996, Cardiovascular research.

[105]  A. Greene,et al.  Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. , 1996, Hypertension.

[106]  Yasuhiko Hayashi,et al.  Possible Participation of Autocrine and Paracrine Vascular Endothelial Growth Factors in Hypoxia-induced Proliferation of Endothelial Cells and Pericytes (*) , 1995, The Journal of Biological Chemistry.

[107]  V. Richard,et al.  Healing of myocardial infarcts in dogs. Effects of late reperfusion. , 1995, Circulation.

[108]  B. Strauer,et al.  Remodelling of intramyocardial arterioles and extracellular matrix in patients with arterial hypertension and impaired coronary reserve. , 1995, European heart journal.

[109]  H. Schunkert,et al.  Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. Captopril and Thrombolysis Study Investigators. , 1995, Journal of the American College of Cardiology.

[110]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.

[111]  B. Rongish,et al.  Coronary neovascularization of embryonic rat hearts cultured in oculo is independent of thyroid hormones. , 1995, The American journal of physiology.

[112]  R. Tomanek,et al.  Compensated coronary microvascular growth in senescent rats with thyroxine-induced cardiac hypertrophy. , 1995, The American journal of physiology.

[113]  G. Baumbach,et al.  Proportional arteriolar growth accompanies cardiac hypertrophy induced by volume overload. , 1994, The American journal of physiology.

[114]  Y. Kira,et al.  Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. , 1994, The American journal of physiology.

[115]  H. Drexler,et al.  Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. , 1994, Circulation.

[116]  X. Xu,et al.  Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. , 1994, The American journal of physiology.

[117]  M. Laughlin,et al.  Exercise training-induced coronary vascular adaptation. , 1992, Journal of applied physiology.

[118]  H. Weiss,et al.  Diffusion distances, total capillary length and mitochondrial volume in pressure-overload myocardial hypertrophy. , 1992, Journal of molecular and cellular cardiology.

[119]  T. Mattfeldt,et al.  Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. , 1992, Hypertension.

[120]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[121]  M. Packer.  The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. , 1992, Journal of the American College of Cardiology.

[122]  K Rakusan,et al.  Morphometry of Human Coronary Capillaries During Normal Growth and the Effect of Age in Left Ventricular Pressure‐Overload Hypertrophy , 1992, Circulation.

[123]  D. Hayoz,et al.  Endothelial function in chronic congestive heart failure. , 1992, The American journal of cardiology.

[124]  A. Sharkey,et al.  Endothelial cells regulate cardiac contractility. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[125]  M. Zile,et al.  Changes in Myocardial Blood Flow During Development of and Recovery From Tachycardia‐Induced Cardiomyopathy , 1992, Circulation.

[126]  M. Zile,et al.  Tachycardia-induced cardiomyopathy: effects on blood flow and capillary structure. , 1991, The American journal of physiology.

[127]  M. Gotsman,et al.  Coronary Capillaries in Patients With Congestive Cardiomyopathy or Angina Pectoris With Patent Main Coronary Arteries: Ultrastructural Morphometry of Endomyocardial Biopsy Samples , 1991, Circulation.

[128]  P. Anversa,et al.  Loss of intermediate-sized coronary arteries and capillary proliferation after left ventricular failure in rats. , 1991, The American journal of physiology.

[129]  J. Keiser,et al.  Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates. , 1991, Circulation research.

[130]  E. Sonnenblick,et al.  Morphometric analysis of coronary capillaries during physiologic myocardial growth and induced cardiac hypertrophy: a review. , 1989, International journal of microcirculation, clinical and experimental.

[131]  P. Anversa,et al.  Capillary Growth in Anemia-Induced Ventricular Wall Remodeling in the Rat Heart , 1989, Circulation research.

[132]  M. Marcus,et al.  Coronary angiogenesis during long-term hypertension and left ventricular hypertrophy in dogs. , 1989, Circulation research.

[133]  S. Kumar,et al.  Can growth of capillaries in the heart and skeletal muscle be explained by the presence of an angiogenic factor? , 1989, British journal of experimental pathology.

[134]  R. Bonow,et al.  Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. , 1988, The New England journal of medicine.

[135]  H R Figulla,et al.  Inhomogenous capillary flow and its prevention by verapamil and hydralazine in the cardiomyopathic Syrian hamster. , 1987, Circulation.

[136]  A Kamiya,et al.  The effect of fluid shear stress on the migration and proliferation of cultured endothelial cells. , 1986, Microvascular research.

[137]  P. Anversa,et al.  Effects of exercise on the capillary vasculature of the rat heart. , 1987, Circulation.

[138]  T. Rink,et al.  Single stretch-activated ion channels in vascular endothelial cells as mechanotransducers? , 1987, Nature.

[139]  J. Hochman,et al.  Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. , 1987, Circulation.

[140]  G Olivetti,et al.  Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review. , 1986, Journal of the American College of Cardiology.

[141]  M. Marcus,et al.  Thyroxine-induced left ventricular hypertrophy in the rat. Anatomical and physiological evidence for angiogenesis. , 1985, Circulation research.

[142]  L. Fernandez,et al.  Neovascularization produced by angiotensin II. , 1985, The Journal of laboratory and clinical medicine.

[143]  E. Sonnenblick,et al.  Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy. , 1985, The American journal of cardiology.

[144]  R. Magorien,et al.  The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy. , 1983, American heart journal.

[145]  E. Sonnenblick,et al.  Hypothesis: is congestive cardiomyopathy caused by a hyperreactive myocardial microcirculation (microvascular spasm)? , 1982, The American journal of cardiology.

[146]  O. Hudlická,et al.  Capillary Growth and Changes in Heart Performance Induced by Chronic Bradycardial Pacing in the Rabbit , 1981, Circulation research.

[147]  E. Williams,et al.  The effect of prolonged propranolol administration on myocardial transmural capillary density in young rabbits. , 1981, The Journal of physiology.

[148]  J. Folkman,et al.  Role of cell shape in growth control , 1978, Nature.

[149]  E. Williams,et al.  MORPHOMETRIC CHANGES IN RABBIT VENTRICULAR MYOCARDIUM PRODUCED BY LONG-TERM BETA-ADRENOCEPTOR BLOCKADE , 1977, The Lancet.